Downloading

Please wait until the download process completes before closing this popup.

Closing this popup before the download process completes will terminate the download.


HT942524Q0107: Army Liposome Formulation (ALF) Phase 2 and 3 Clinical Trials

Primary Contact Name


A Material Safety Data Sheet (MSDS) must be attached to offer submissions in accordance with FAR Clause 52.223-3.
Name Number File/URL Date Document Type Include in Response
B08_Amended_Solicitaiton_HT942524Q0107_02 B08_Amended_Solicitaiton_HT942524Q0107_02.pdf 2024-08-15 Attachment No
Update / Notice ID Description Posted Date Response Date
0001 Please see amended solicitation HT942524Q0107-01 to provide answers to questions receivedXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXPlease see Solicitation document HT942524Q0 2024/08/14 18:26 UTC 2024-08-23 10:00 Eastern Standard Time
HT942524Q0107 Please see Solicitation document HT942524Q0107 along with the attachments: Minimum Essential Characteristics (MEC), Statement of Objective (SOO) and SOO Appendix A 2024/07/23 13:10 UTC 2024-08-23 10:00 Eastern Standard Time